Insight into the differences in classification of mediastinal and hilar lymph nodes between Wang’s lymph node map and the International Association for the Study of Lung Cancer lymph node map
Insight into the differences in classification of mediastinal and hilar lymph nodes between Wang’s lymph node map and the International Association for the Study of Lung Cancer lymph node map
复制标题
深入探讨Wang氏淋巴结图与国际肺癌研究协会淋巴结图纵隔和肺门淋巴结分类的差异
DOI:
--
复制
发表时间:
2015
影响因子:
2.5
通讯作者:
Su-Qin Ben
中科院分区:
文献类型:
--
作者:
Ya-Qing Li;Ko-Pen Wang;Su-Qin Ben
Lung cancer is the leading cause of malignant-tumor-related morbidity and mortality worldwide. Transbronchial needle aspiration (TBNA) has for the past 30 years been an effective technique for the diagnosis and staging of lung cancer. Understanding the anatomy of mediastinal and hilar lymph nodes is essential to improve the yield of TBNA. Wang’s lymph node map is based on the lymph node map of the American Thoracic Society (ATS), and on the TBNA technique; it was published in 1994, and has promoted the development of both conventional TBNA (cTBNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In 2009, the International Association for the Study of Lung Cancer (IASLC) developed a new chest lymph node map to reconcile the differences between the Naruke and The Mountain-Dresler (MD)-ATS lymph node maps. The IASLC lymph node map was incorporated into the seventh edition of the tumor, node, metastasis (TNM) staging system for lung cancer, which directly affected the treatment and prognosis of lung cancer. There are significant differences between Wang’s lymph node map and the IASLC lymph node map in TNM staging, and it is imperative to understand these differences and correlate these maps for the prognosis and staging of lung cancer using cTBNA or EBUS-TBNA..